Drug recall
0.25% BUPIVACAINE HCL and EPINEPHRINE 1:200,000 Injection, 30 mL Single-dose Vials, Sterile, nonpyrogenic, Rx…
FDA recall event 26729 · Class III · ABBOTT LABS
Key facts
| Event ID | 26729 |
|---|---|
| Recall numbers | D-303-3 |
| Recalling firm | ABBOTT LABS |
| Product type | Drugs |
| Products | 0.25% BUPIVACAINE HCL and EPINEPHRINE 1:200,000 Injection, 30 mL Single-dose Vials, Sterile, nonpyrogenic, Rx only, Abbott Labs., N. Chicago, IL 60064 NDC 0074-9042-02 |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Mislabeled; expiration date is incorrectly printed on vial label as "1 October 200" rather than correctly as "1 October 2004" |
| Initiation date | Jul 15, 2003 |
| City | NORTH CHICAGO |
| Country | United States |
| FEI number | 3001630466 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports